Isomorphic Labs
To add a bio or update company history, please click update information.
News from Isomorphic Labs
Isomorphic Labs
11 May 2026
Isomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidates
Isomorphic Labs develops AI models for drug discovery and drug design across multiple therapeutic areas and drug types. IsoDDE helps researchers predict biological systems and identify potential drug candidates for pharmaceutical development.
Isomorphic Labs
31 Mar 2025
Isomorphic Labs raises over £450m in Series A funding led by Thrive Capital to scale AI drug design and clinical programmes
Isomorphic Labs applies advanced AI models to drug discovery, accelerating the design of new medicines across multiple therapeutic areas and partnering with global pharmaceutical companies.
Isomorphic Labs
- Life Sciences
- London, United Kingdom
- £1.9bn
- isomorphiclabs.com
- Update Information
More venture news
- 12 Aug 2026
CN BioCN Bio secures a £180k Innovate UK grant to develop organ-on-a-chip system for drug behaviour predictions
GrantLife Sciences - 5 Aug 2026
MironidMironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases
Series BLife Sciences - 29 Jul 2026
QureightQureight lands £15m Series B led by Molten Ventures to bring AI imaging to clinical trials for lung and heart disease
Series BLife Sciences
